• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Uncharacterized protein C7orf43 (C7orf43)

ACP12992

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP12992 Target NameC7orf43
Target SynonymsMAP11; C7orf43Microtubule-associated protein 11FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-580
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8WVR3
Background Information
  • Uniprot Id

    Q8WVR3

  • Target Species

    Human

  • Target Name

    TRAPPC14

  • Target Full Name

    Trafficking protein particle complex subunit 14

  • Target Function

    Specific subunit of the TRAPP (transport protein particle) II complex, a highly conserved vesicle tethering complex that functions in late Golgi trafficking as a membrane tether. TRAPP II complex has also GEF activity toward RAB1A. TRAPPC14 is dispensable for TRAPPII complex integrity but mediates RAB3IP preciliary vesicle trafficking to the mother centriole during ciliogenesis. Modulates YAP1 activity as transcriptional regulator.

  • Target Subcellular Location

    Cytoplasm, cytoskeleton, spindle. Vesicle. Midbody. Cytoplasm.

  • Target Tissue Specificity

    Broadly expressed. High levels in brain, cerebellum, testis and whole blood.

  • Target Synonyms

    MAP11; C7orf43Microtubule-associated protein 11

Inquire Recombinant Human Uncharacterized protein C7orf43 (C7orf43) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification